BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tomasello G, Ghidini M, Barni S, Passalacqua R, Petrelli F. Overview of different available chemotherapy regimens combined with radiotherapy for the neoadjuvant and definitive treatment of esophageal cancer. Expert Rev Clin Pharmacol 2017;10:649-60. [PMID: 28349718 DOI: 10.1080/17512433.2017.1313112] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Zhang L, Hall M, Bastola D. Utilizing Twitter data for analysis of chemotherapy. International Journal of Medical Informatics 2018;120:92-100. [DOI: 10.1016/j.ijmedinf.2018.10.002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 16] [Article Influence: 8.3] [Reference Citation Analysis]
2 Peng J, Shi S, Yu J, Liu J, Wei H, Song H, Wang S, Li Z, He S, Li L, Zhang H, Yan Z, Zhao R, Liu Y, Liu Y, Li J, Zhang R, Wang W. miR-378d suppresses malignant phenotype of ESCC cells through AKT signaling. Cancer Cell Int 2021;21. [DOI: 10.1186/s12935-021-02403-y] [Reference Citation Analysis]
3 Crull DJ, Hogenes MCH, Hoekstra R, Hendriksen EM, van Det MJ, Kouwenhoven EA. The Impact of Tumor Regression on Prognosis After Neoadjuvant Chemoradiotherapy in Surgically Treated Esophageal Adenocarcinoma. Ann Surg Oncol. [DOI: 10.1245/s10434-022-11336-3] [Reference Citation Analysis]
4 Gao Y, Chen DL, Zhou M, Zheng ZS, He MF, Huang S, Liao XZ, Zhang JX. Cordycepin enhances the chemosensitivity of esophageal cancer cells to cisplatin by inducing the activation of AMPK and suppressing the AKT signaling pathway. Cell Death Dis 2020;11:866. [PMID: 33067427 DOI: 10.1038/s41419-020-03079-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Guo XF, Li SS, Zhu XF, Dou QH, Liu D. Lapatinib in combination with paclitaxel plays synergistic antitumor effects on esophageal squamous cancer. Cancer Chemother Pharmacol 2018;82:383-94. [PMID: 29909520 DOI: 10.1007/s00280-018-3627-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
6 Assali M, Kittana N, Qasem SA, Adas R, Saleh D, Arar A, Zohud O. Combretastatin A4-camptothecin micelles as combination therapy for effective anticancer activity. RSC Adv 2019;9:1055-61. [DOI: 10.1039/c8ra08794f] [Cited by in Crossref: 8] [Article Influence: 2.7] [Reference Citation Analysis]
7 Zhu K, Ren P, Yang Y, Wang Y, Xiao W, Zhang H, Yu Z. Role of chemotherapy after curative esophagectomy in squamous cell carcinoma of the thoracic esophagus: A propensity score-matched analysis. Thorac Cancer 2021;12:1800-9. [PMID: 33943011 DOI: 10.1111/1759-7714.13981] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Anderluh F, Toplak M, Velenik V, Oblak I, Ermenc AS, Peressutti AJ, But-Hadzic J, Vidmar MS. Definitive radiochemotherapy in esophageal cancer - a single institution experience. Radiol Oncol 2019;53:480-7. [PMID: 31747382 DOI: 10.2478/raon-2019-0054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]